IITRI

Investigate.Collaborate.Communicate

ADVANCING SCIENCE TOGETHER

10 West 35th Street. Chicago, IL 60616

extend your your scientific team

IITRI collaborates with sponsors to establish a true partnership for the planning and execution of each study. Talk to us about your program today!

IITRI

Investigate.Collaborate.Communicate

ADVANCING SCIENCE TOGETHER

10 West 35th Street. Chicago, IL 60616

extend of your scientific team

IITRI collaborates with sponsors to establish a true partnership for the planning and execution of each study. Talk to us about your program today!

Our Experience is Exceptional

preclinical development services 

Over the past 40 years IITRI has established itself as a top-quality, full-service GLP-compliant preclinical contract research organization (CRO) that provides the complete IND-enabling preclinical safety and toxicology testing programs of a large CRO, with the personalized attention of a smaller organization.

We strive to establish a true partnership with our sponsors for the planning and execution of each study.

We offer accomplished study teams, with experienced and highly accessible PhD and DABT study directors having over 15 years’ tenure, and degreed technicians to conduct your study and provide information on study progress and early results throughout the program.  

IITRI specializes in GLP toxicology and safety studies, IND-enabling programs, infectious disease vaccine and therapeutic development, and inhalation toxicology programs for the biotech, pharmaceutical, and government sponsors. 

NEWS AND EVENTS

Hamster and ferret models available for COVID-19 studies

Hamster and ferret models available for COVID-19 studies

Ferret infection model: Since early in the pandemic, IITRI has been working on developing new animal models to test out therapeutics and treatments for COVID-19 (in addition to in vitro offerings of efficacy assays, neutralization assays, and surface decontaminant...

Promising antiviral activity of Moleculin’s drug candidate

Promising antiviral activity of Moleculin’s drug candidate

IITRI is proud to share the promising news of one of our partners, Moleculin!  Our team here at IITRI was contracted to perform additional in vitro testing of their drug candidate (WP1122) for antiviral effects against SARS-CoV-2. We used growth medium that more...

IITRI has developed a new bleomycin mouse model

IITRI has developed a new bleomycin mouse model

IITRI now offers an improved bleomycin (BLM) induced pulmonary fibrosis mouse model that can recapitulate many of the complex profibrotic responses that are also observed in the lungs of those suffering from idiopathic pulmonary fibrosis (IPF) and perhaps COVID-19...